AHA Advises OSA Screening for Those With CV Risk, Conditions
Screening for obstructive sleep apnea recommended for those with resistant/poorly controlled HTN, pulmonary HTN, recurrent a-fib
Obstructive Sleep Apnea
Novel Rx Device for Sleep Apnea, Snoring Gets FDA Approval
The eXciteOSA device is used while the individual is awake and provides electrical muscle stimulation through a mouthpiece that sits around the tongue.
Effect of Positive Airway Pressure Therapy on Cardiovascular Risk in Sleep Apnea
Patients with sleep apnea who received positive airway pressure therapy did not exhibit reduced cardiovascular risk compared with patients who received usual care.
Transvenous Phrenic Nerve Stimulation Safe, Efficacious in Central Sleep Apnea
Researchers examined patients with central sleep apnea after 5 years of treatment with transvenous phrenic nerve stimulation therapy.
AAP: Choosing Wisely Recs on Pediatric Pulmonology, Sleep Medicine
The list, titled “Five Things Physicians and Patients Should Question,” was developed by members of the AAP Section on Pediatric Pulmonology and Sleep Medicine.
CPAP Therapy for 6 Months in OSA May Reverse Metabolic Syndrome
Continuous positive airway pressure therapy for 6 months offers patients with obstructive sleep apnea a greater chance of reversing metabolic syndrome.
Specificities and Sensitivities of OSA Screening Tools for People With HIV
In terms of screening for obstructive sleep apnea in people living with HIV, the STOP-BANG questionnaire had good sensitivity, whereas the Berlin questionnaire and the Epworth Sleepiness Scale demonstrated good specificity.
Pitolisant Add-On CPAP Therapy Reduces Excessive Daytime Sleepiness in OSA
Pitolisant may be used as an add-on therapy to continuous positive airway pressure in patients with obstructive sleep apnea suffering from residual diurnal somnolence.
Inspire Therapy Approved for Younger Patients With Obstructive Sleep Apnea
The Food and Drug Administration (FDA) has expanded the approval of Inspire therapy (Inspire Medical Systems) to include patients aged 18 to 21 years with moderate to severe obstructive sleep apnea (OSA) who are unable to use continuous positive airway pressure (CPAP). Previously, the therapy was only approved for patients 22 years of age and…
Guidelines Issued for Insomnia, Sleep Apnea in Current, Former Soldiers
VA and DoD joint guideline addresses sleep disorders in military personnel and veterans.
